This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
November 14, 2016
Cook Children’s Hospital in Texas acquires NBS System from Nexstim Plc
November 14, 2016
Nordic Nanovector to Present at Jefferies 2016 London Healthcare Conference
November 11, 2016
Wilson Therapeutics presents updated preliminary clinical data on WTX101 at the AASLD Liver Meeting
November 10, 2016
Targovax granted European Patent for ONCOS platform lead product, ONCOS-102
November 09, 2016
GenSight Biologics wins 2016 Deloitte Technology Fast 50 “Biotech of the Future” Award for the Paris region
November 08, 2016
Cerenis Therapeutics Announces Last Patient Dosed in CARAT Phase II Study with CER-001 in Post-Acute Coronary Syndrome Patients
November 07, 2016
Coverage regarding Targovax’s presentation at ESGCT/ISSCR Stem Cells & Gene Therapy Symposium
November 07, 2016
Cash position and revenue for Q3 2016
November 04, 2016
Onxeo Announces Promising Results from Preclinical Studies of Livatag® in Pancreatic Cancer
November 04, 2016
Safety Review Committee for Nordic Nanovector’s Lymrit 37-01 trial recommends dose escalation to 20 MBq/kg with Betalutin®